Skip to main content

Advertisement

Log in

Adhesion molecules and p16 expression in endocervical adenocarcinoma

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

An immunohistochemical (IHC) study has been conducted on 34 cases of untreated endocervical adenocarcinomas collected among three institutions (Ospedale S. Andrea, Rome; Istituto Nazionale Tumori “Fondazione G. Pascale”, Naples; and Clinica Malzoni, Avellino). The E-cadherin and α- and β-catenin complex status has been investigated along with p16INK4a in all studied cases with the aim to study whether the pattern of expression of the cadherin–catenin complex could be causally related to the expression of P16INK4a protein. Results were evaluated for statistical significance by a non-parametric test (Kruskal–Wallis). Endocervical adenocarcinomas as a group were uniformly expressing p16INK4a except for two cases, and all lesions displayed downregulation of the cadherin–catenin complex, without demonstrating statistically significant differences among the different histotypes. The lack of nuclear accumulation of β-catenin found in this group of lesions probably implies that no alteration of the β-catenin/Wnt metabolic pathway is present in endocervical adenocarcinoma, as opposed to what is found in the literature for squamous carcinoma of the cervix. The diffuse expression of p16INK4a protein in this group of neoplasms stresses the important role of high-risk human papillomavirus infection in neoplastic causation possibly via the viral E7-mediated inactivation of pRB tumor-suppressor protein and also underlines the useful role of p16INK4a immunostaining in the diagnostic algorithm of endocervical adenocarcinomas. In consideration of these findings, investigation of downstream β-catenin genes c-myc and cyclin D1 is sought as possibly contributive in the molecular pathogenesis of endocervical adenocarcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Smith HO, Tiffany MF, Qualls CR et al (2000) The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States. A 24-year population-based study. Gynecol Oncol 78:97–105

    Article  PubMed  CAS  Google Scholar 

  2. Schoolland M, Allpress S, Sterret GF (2002) Adenocarcinoma of the cervix. Cancer 96:5–13

    Article  PubMed  Google Scholar 

  3. Takeichi M (1993) Cadherins in cancer: implication for invasion and metastasis. Curr Opin Cell Biol 5:806–811

    Article  PubMed  CAS  Google Scholar 

  4. Shiozaki H, Oka H, Inoue M et al (1996) E-cadherin mediated adhesion system in cancer cells. Cancer 77:1605–1613

    PubMed  CAS  Google Scholar 

  5. Piepenhagen PA, Nelson WJ (1993) Defining E-cadherin associated protein complexes in epithelial cells: plakoglobin, β-catenin and γ-catenin are distinct components. J Cell Sci 104:751–762

    PubMed  CAS  Google Scholar 

  6. Hinck L, Nathke IS, Papkoff J et al (1994) Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J Cell Biol 125:1327–1340

    Article  PubMed  CAS  Google Scholar 

  7. Boggon TJ, Murray J, Chappuis-Flament S et al (2002) C-cadherin ectodomain structure and implications for cell adhesion mechanisms. Science 296:1308–1313

    Article  PubMed  CAS  Google Scholar 

  8. Frixen UH, Beherens J, Sachs M et al (1991) E-cadherin mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113:173–185

    Article  PubMed  CAS  Google Scholar 

  9. Van Aken E, De Wever O, Correia da Rocha AS et al (2001) Defective E-cadherin/catenin complexes in human cancer. Virchows Arch 439:725–751

    PubMed  Google Scholar 

  10. Cerrato A, Fulciniti F, Avallone A et al (1998) Beta- and gamma-catenin expression in thyroid carcinomas. J Pathol 185(3):267–272

    Article  PubMed  CAS  Google Scholar 

  11. Buongiorno PF, al-Kasspooles M, Lee SW et al (1995) E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett’s oesophagus. Br J Cancer 71:166–172

    Google Scholar 

  12. Siitonen SM, Kononen JTT, Helin HJ et al (1996) Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol 105:394–402

    PubMed  CAS  Google Scholar 

  13. Sung-Chul L, Mi-Sook L (2002) Significance of E-cadherin/β-catenin complex and Cyclin D1 in breast cancer. Oncol Rep 9:915–928

    Google Scholar 

  14. Oka H, Shiozaki H, Kobayashi K et al (1992) Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer. Virchows Arch A Pathol Anat Histopathol 421:149–156

    Article  PubMed  CAS  Google Scholar 

  15. Weinel RJ, Neumann K, Kisker O et al (1996) Expression and potential role of E-cadherin in pancreatic carcinoma. Int J Pancreatol 19:25–30

    PubMed  CAS  Google Scholar 

  16. Wakatsuki S, Watanabe R, Saito K et al (1996) Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder. Cancer Lett 103:11–17

    Article  PubMed  CAS  Google Scholar 

  17. Cheng L, Nagabhushan M, Pretlow TP et al (1996) Expression of E-cadherin in primary and metastatic prostate cancer. Am J Pathol 148:1375–1380

    PubMed  CAS  Google Scholar 

  18. Danen EH, de Vries TJ, Morandini R et al (1996) E-cadherin expression in human melanoma. Melanoma Res 6:127–131

    Article  PubMed  CAS  Google Scholar 

  19. Tohma Y, Yamashima T, Yamashita J (1992) Immunohistochemical localization of cell adhesion molecule epithelial cadherin in human arachnoid villi and meningiomas. Cancer Res 52:1981–1987

    PubMed  CAS  Google Scholar 

  20. Vessey CJ, Wilding J, Folarin N et al (1995) Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J Pathol 176:151–159

    Article  PubMed  CAS  Google Scholar 

  21. Carico E, Atlante M, Bucci B et al (2001) E-Cadherin and α-catenin expression during tumor progression of cervical epithelium. Gynecol Oncol 80:156–161

    Article  PubMed  CAS  Google Scholar 

  22. Hideyuki N, Tsuyoshi S, Hiroshi Y et al (1999) Nuclear localization of β-catenin in normal and carcinogenic endometrium. Mol Carcinog 25:207–218

    Article  Google Scholar 

  23. Moreno-Bueno G, Hardisson D, Sarrio D et al (2003) Abnormalities of E- and P-cadherin and catenin (beta-, gamma catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia. J Pathol 199:471–478

    Article  PubMed  CAS  Google Scholar 

  24. Shih HC, Shiozawa T, Miyamoto T et al (2004) Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression. Anticancer Res 24:3843–3850

    PubMed  CAS  Google Scholar 

  25. Veatch AL, Carson LF, Ramakrishnan S (1994) Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells. Int J Cancer 58:393–399

    Article  PubMed  CAS  Google Scholar 

  26. Heathley MK (2004) E-cadherin and catenin expression in normal and neoplastic endocervical epithelium. Histopathology 45:200–202

    Article  Google Scholar 

  27. Imura J, Ichikawa K, Takeda J et al (2001) Beta catenin expression as a prognostic indicator in cervical adenocarcinoma. Int J Mol Med 8:353–358

    PubMed  CAS  Google Scholar 

  28. Fadare O, Reddy H, Wang J et al (2005) E- cadherin and β-catenin expression in early stage cervical carcinoma: a tissue microarray study of 147 cases. World J Surg Oncol 3:38

    Article  PubMed  Google Scholar 

  29. Negri G, Egarter-Vigl E, Kasal A et al (2003) p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol 2:187–193

    Article  Google Scholar 

  30. Carozzi F, Confortini M, Dalla Palma P, New Technologies for Cervical Cancer Screening (NTCC) Working Group et al (2008) Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial. Lancet Oncol 10:937–945

    Article  CAS  Google Scholar 

  31. Pérez-Plasencia C, Vázquez-Ortiz G, López-Romero R et al (2007) Genome wide expression analysis in HPV 16 Cervical cancer: identification of altered metabolic pathways. Infect Agents Cancer 2:16

    Article  PubMed  CAS  Google Scholar 

  32. Pérez-Plasencia C, Duenas-Gonzalez A, Alatorre-Tavera B (2008) Second hit in cervical carcinogenesis process: involvement of Wnt/beta catenin pathway. Int Arch Med 1(1):10

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors gratefully thank Dr. Emiliano Palmieri, M.D., for performing statistical evaluation of data, and the Lega Ialiana per la Lotta ai Tumori (LILT, Sezione di Napoli) for the generous contribution to this study. The authors would like to thank Dr. Alessandra Trocino for her excellent bibliographic services.

Conflict of interest statement

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Franco Fulciniti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carico, E., Fulciniti, F., Giovagnoli, M.R. et al. Adhesion molecules and p16 expression in endocervical adenocarcinoma. Virchows Arch 455, 245–251 (2009). https://doi.org/10.1007/s00428-009-0811-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-009-0811-1

Keywords

Navigation